The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 12, 2016

Filed:

Sep. 17, 2013
Applicants:

Abbott Gmbh & Co. KG, Wiesbaden, DE;

Abbvie Inc., North Chicago, IL (US);

Inventors:

Hervé Geneste, Ludwigshafen, DE;

Michael Ochse, Ludwigshafen, DE;

Karla Drescher, Ludwigshafen, DE;

Clarissa Jakob, North Chicago, IL (US);

Maricel Torrent, Lake Bluff, IL (US);

Assignees:

AbbVie Inc., North Chicago, IL (US);

Abbott GmbH & Co. KG, Wiesbaden, DE;

Attorney:
Int. Cl.
CPC ...
C07D 491/14 (2006.01); C07D 495/14 (2006.01); C07D 498/14 (2006.01); C07D 513/14 (2006.01); A61K 31/4985 (2006.01); A61P 25/18 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); A61P 25/30 (2006.01); A61P 3/04 (2006.01); C07D 471/14 (2006.01); C07D 491/04 (2006.01); C07D 495/04 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 471/14 (2013.01); A61K 31/4985 (2013.01); C07D 491/04 (2013.01); C07D 491/14 (2013.01); C07D 495/04 (2013.01); C07D 495/14 (2013.01); C07D 498/04 (2013.01); C07D 498/14 (2013.01); C07D 513/14 (2013.01);
Abstract

The present invention relates to compounds of the formula I, the N-oxides, tautomers, the prodrugs and the pharmaceutically acceptable salts thereof. The compounds of the formula I, the N-oxides, tautomers, the prodrugs and the pharmaceutically acceptable salts thereof are inhibitors of phosphodiesterase type 10A and to their use for the manufacture of a medicament and which thus are suitable for treating or controlling of medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders.


Find Patent Forward Citations

Loading…